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ABSTRACT
Mitogen-activated protein kinases (MAPKs) regulate normal brain functioning and their 
dysfunction is implicated in a number of brain disorders. Thus, there is great interest in 
understanding the signalling systems that control MAPK functioning. One family of proteins 
that contribute to this process, the mitogen-activated protein kinase phosphatases (MKPs), 
directly inactivate MAPKs through dephosphorylation. Recent studies have identified novel 
functions of MKPs in foetal development, the immune system, cancer and synaptic plasticity 
and memory. In the present study, we performed an unbiased investigation using MKP-2-/- mice 
to assess whether MKP-2 plays a global role in modulating brain function.  Local cerebral 
glucose utilization is significantly increased in the ventral tegmental area (VTA) of                
MKP-2-/- mice, with connectivity analysis revealing alterations in VTA functional connectivity, 
including a significant reduction in connectivity to the nucleus accumbens and hippocampus. 
In addition, spontaneous excitatory postsynaptic current frequency, but not amplitude, onto 
putative dopamine neurons in the VTA is increased in MKP-2-/- mice, which indicates that 
increased excitatory drive may account for the increased VTA glucose utilization. Consistent 
with modified VTA function and connectivity, in behavioural tests MKP-2-/- mice exhibited 
increased sucrose preference and impaired amphetamine-induced hyperlocomotion. Overall, 
these data reveal that MKP-2 plays a role in modulating VTA function and that its dysfunction 
may contribute to brain disorders in which altered reward processing is present. 




ACSF - artificial cerebrospinal fluid
BDNF - brain-derived neurotrophic factor
BSA - bovine serum albumin 
CNS - central nervous system
DA - dopamine
DUSP - dual-specificity phosphatases
ERK - extracellular signal related kinase
FBS - fetal bovine serum 
JNK - c-jun N-terminal kinase
LCGU - local cerebral glucose utilization
MAPK - mitogen-activated protein kinase
MKP - mitogen-activated protein kinase phosphatase
NDS – normal donkey serum
PLSR - partial least squares regression algorithm
PBS - phosphate-buffered saline
PFA - paraformaldehyde  
RoI - region of interest
sEPSC - spontaneous excitatory postsynaptic current
SPT - sucrose preference test
TH - tyrosine hydroxylase
VIP - variable importance to the projection
VTA - ventral tegmental area
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1 |  INTRODUCTION
The mitogen-activated protein kinases (MAPK) form a family of evolutionally conserved 
proteins, which play a critical role in various cellular processes including cellular proliferation, 
differentiation, development, transformation and apoptosis (Keshet and Seger, 2010). The 
mammalian MAPK family consists of the extracellular signal related kinase (ERK), the c-jun 
N-terminal kinase (JNK) and p38 MAPK. MAPK signalling shares a common three-tiered core 
structure, where the activation of MAPK requires sequential phosphorylation and activation of 
each component kinase. The activated MAPKs then convert the extracellular stimuli into a 
broad range of cellular responses. In the central nervous system (CNS), MAPKs are expressed 
in numerous cell types, where they play a role in the regulation of synaptic transmission and 
plasticity (Thomas and Huganir, 2004; Samuels et al., 2009). In addition, their dysfunction has 
been implicated in CNS disorders including Alzheimer’s disease, autism, Parkinson’s disease, 
anxiety and addiction (Yasuda et al., 2011; Lee & Kim, 2017; Vithayathil et al., 2018). 
 
The duration and magnitude of MAPK activation are crucial in determining the physiological 
outcome of this signalling pathway (Marshall, 1995; Caunt & Keyse, 2013). Thus, the negative 
regulation of phosphorylation process is vital for controlling MAPK signalling. The process of 
MAPK inactivation is mediated by the family of dual-specificity phosphatases (DUSPs), the 
mitogen-activated protein kinase phosphatases (MKPs), which catalyse the dephosphorylation 
of MAPK that consequently leads to inhibiting their activity. However, our knowledge of MKP 
function in the CNS is limited but studies suggest a role for the prototypic Dusp1 (MKP-1) in 
brain-derived neurotrophic factor (BDNF)-induced axonal branching (Jeanneteau et al., 2010) 
and depression (Duric et al., 2010; Chen et al., 2012; Jia et al., 2013; Hui et al., 2016; Barthas 
et al., 2017). In contrast, the role of Dusp4 (MKP-2) in the CNS has not been studied 
extensively. However, we have recently shown that Dusp4 deletion increases hippocampal 
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spontaneous excitatory postsynaptic potential (sEPSC) frequency as well as impairing spatial 
reference and working memory (Abdul Rahman et al., 2016). 
Building on our previous findings and given our limited knowledge of MKP-2 function in the 
CNS, we performed an unbiased investigation using MKP-2-/- mice to examine the consequence 
of Dusp4 gene deletion on brain function and behaviour.
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2 |  MATERIALS AND METHODS
2.1 |  Animals 
All in vivo experimental procedures were in accordance with UK legislation (Animals 
(Scientific Procedures) Act 1986) and with approval by the University of Strathclyde Ethics 
Committee. All experiments were completed using male MKP-2+/+ and MKP-2-/- mice 
generated as previously described (Al-Mutairi et al., 2010), normally group-housed (5–6 per 
cage) under standard conditions (21°C, 45%–65% humidity, 12h dark/light cycle [lights on 
06:00]) in cages provided with environmental enrichment in the form of a plastic refuge and 
nesting material. Animals had free access to food and water with all behavioural procedures 
carried out between 09.00 and 17.00. Mice were randomly assigned to the treatment groups 
with the experimenter blinded to each group. 
2.2 | 14C-2-Deoxyglucose (14C-2-DG) functional brain imaging 
Local cerebral glucose utilization (LCGU) was determined in MKP-2-/- (n = 11) and MKP- 2+/+ 
(n = 10) mice (10-12 weeks old) in accordance with previously published protocols , using an 
approach adapted from the original protocol developed in rats (Sokoloff et al., 1977) for 
application in conscious freely-moving mice (Dawson et al., 2011, 2013). In brief, LCGU 
measurement was initiated by injection of 14C-2-DG (intraperitoneally (i.p.), 4.625 MBq/kg in 
physiological saline at 2.5ml/kg (Perkin-Elmer, UK) and animals were returned to their home 
cage. Forty five minutes after 14C-2-DG injection animals were decapitated and a terminal 
blood sample collected, by torso inversion, into heparinized weigh boats. Plasma glucose 
concentrations (mmol/L) were detected from whole blood using a blood glucose monitor 
(Accu-Chek Aviva). The brain was then rapidly dissected out intact, frozen in isopentane (-
40oC) and stored at (-80oC) until sectioning. Blood samples were centrifuged to isolate plasma, 
and plasma 14C concentrations (20μl) were determine by liquid scintillation analysis (Packard). 
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Frozen brains were sectioned (20μm) in the coronal plane in a cryostat (-20oC). A series of 
three consecutive sections were retained from every 60μm, thaw mounted onto slide covers and 
rapidly dried on a hotplate (70oC). Autoradiograms were generated by apposing these sections, 
together with precalibrated 14C standards (39-1098 nCi/g tissue equivalents, Amersham 
International, UK) to x-ray film (Carestream BioMax MR film, Sigma-Aldrich, UK) for 7 days. 
Autoradiographic images were analysed by a computer based image analysis system 
(MCID/M5+, Interfocus, UK). The local isotope concentration for each brain region of interest 
(RoI) was derived from the optical density of the autoradiographic images relative to that of the 
coexposed 14C standards, with 8-12 replicate measurements taken per RoI in each animal. 
LCGU was determined in 53 anatomically distinct brain RoI as the ratio of 14C present in that 
region relative to the average 14C-2-DG concentration in the whole brain of the same animal, 
referred to as the 14C-2-DG uptake ratio. There was no significant difference between the whole 
brain average 14C-2-DG concentration in MKP-2-/- mice relative to wild-type controls (MKP-
2+/+ 142.05 ± 7.74 nCi/g; MKP-2-/- 164.80 ± 8.27 nCi/g, p=0.103 Student’s t-test), suggesting 
that MKP-2 deletion did not significantly impact global cerebral metabolism. In addition, there 
was no significant difference in plasma 14C-2-DG levels (MKP-2+/+ 22.9 ± 1.58 nCi/ml, MKP-2-
/- 29.21 ± 3.33 nCi/ml, p=0.115 Student’s t-test) or glucose levels (MKP-2+/+ 9.00 ± 0.35 
mmol/L, MKP-2-/- 8.28 ± 0.46 mmol/L, p=0.224 Student’s t-test) between the two experimental 
groups, suggesting that there were no systematic difference in plasma glucose or 14C-2-DG 
concentrations between the two experimental groups that might impact on LCGU measurement.
2.3 |  Functional brain connectivity analysis using PLSR 
The partial least squares regression algorithm (PLSR) was employed to define significant 
differences in the functional connectivity of selected “seed” RoI to all other RoI analysed from 
the functional 14C-2-DG brain imaging data, as previously outlined (Dawson et al., 2012, 2013; 
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Hughes et al., 2019), and was undertaken using the PLS package (Mevik and Wehrens, 2007) 
in R (R Core Team, 2018). The analysed “seed” brain RoI were those regions in which a 
significant alteration in overt LCGU was observed, namely the ventral tegmental area (VTA, 
Figure 1). In brief, functional connectivity between the “seed” RoI and all other RoI analysed 
was defined by the variable importance to the projection (VIP) statistic gained from the PLSR 
models. A region was considered to be functionally connected to the “seed” region if the 95% 
confidence interval (95% CI) of the VIP statistic exceeded 0.8. This denotes a considerable 
contribution of the explanatory variable (RoI metabolism) to the dependent variable (“seed” 
RoI metabolism) in PLSR models. The standard deviation (SD) and 95% CI of the VIP statistic 
were estimated by jack-knifing. Significant differences in the VIP statistic between groups were 
analysed using t-test with Bonferroni post-hoc correction for multiple comparisons on the basis 
of the number of potentially connected RoI (52). Thus genotype-induced alterations in regional 
functional connectivity to the VTA were defined in terms of lost (VIP 95% CI >0.8 in MKP-
2+/+ mice, VIP 95% CI <0.8 in MKP-2+/- mice and p<0.05 significant difference between 
genotypes) and abnormally gained (VIP 95% CI <0.8 in MKP-2+/+ mice, VIP 95% CI >0.8 in 
MKP-2+/- mice and p<0.05 significant difference between genotypes) connectivity in MKP-2-/- 
mice.
2.4 |  Electrophysiology 
Mice (19–25 days old) were killed by cervical dislocation and decapitated. The brains were 
rapidly removed and placed immediately in an ice-cold (0–3°C), oxygenated (95% O2/5% CO2) 
artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 3 KCl, 26 NaHCO3, 2.5 
NaH2PO4, 2 MgSO4, 2 CaCl2, 10 glucose. Horizontal slices (230 μm) were cut using a 
vibratome and transferred to a holding chamber containing oxygenated ACSF, equilibrated at 
37oC for 30 min followed for 30 min at the room temperature prior to recording. Slices were 
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then transferred into a submerged recording chamber continuously perfused with ACSF at a 
flow rate at 2-3 mL min-1 at room temperature. Electrodes (4-7 MΩ) were filled with an internal 
solution containing (in mM): 130 KMeSO4, 20 KCl, 4 Mg-ATP, 0.4 Na-GTP, 0.5 EGTA, 10 
HEPES, 0.5% (w/v) biocytin, pH 7.2, 290 mOsm. Visually-guided whole-cell patch-clamp 
recordings were made from neurons in the VTA using an Axopatch 200B amplifier (Molecular 
Devices, USA), connected to a personal computer interfaced with Digidata 1322A interface 
(Molecular Devices, USA) and captured using pClamp9.0 software (Molecular Devices, USA). 
Spontaneous EPSCs were recorded at -70mV for 5 min periods, digitized at 5kHz. For IH 
recordings, cells were held at -70mV in voltage clamp mode with -10mV increments at 10s 
intervals. Data were analysed offline using pClamp9.2 software (Molecular Devices, USA) or 
MiniAnalysis software (Synaptosoft, USA). For all slice experiments, n is equal to one neuron 
per slice per animal with all IH positive neurons confirmed to be dopaminergic (DAergic) 
neurons post experiment using immunohistochemistry (see below).
2.5 |  Immunohistochemistry
2.5.1 |  Confirmation of VTA dopamine (DA) neuron identity
Immediately following electrophysiological experiments, each slice was fixed in 4% 
paraformaldehyde (PFA) for 1 h, then washed with phosphate-buffered saline (PBS).  Slices 
were then agitated in PBS with 1% Triton X-100 for 1 h. Free-floating slices were then pre-
blocked for 1 h at room temperature in PBS with 0.5% Triton X-100, 1% (w/v) bovine serum 
albumin (BSA) and 5% (v/v) fetal bovine serum (FBS) and incubated overnight at 4°C with 
chicken polyclonal anti-tyrosine hydroxylase (TH) antibody (1:500, Abcam, ab76442) with 
0.5% Triton X-100, 1% (w/v) BSA and 5% (v/v) FBS. Slices were rinsed in PBS and incubated 
for 3 h with goat anti-chicken Alexa FluorTM 555 (1:200, Life Technologies, A21437) and 
streptavidin-Alexa FluorTM 488 (1: 500, Life Technologies, S11223) with 0.5% Triton X-100, 
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1% (w/v) BSA and 5% (v/v) FBS. After subsequent PBS rinses, slices were mounted on slides 
using Vectashield anti-fade mounting medium with DAPI (Vector Laboratories) and visualized 
using a Leica SP5 confocal laser-scanning microscope. 
2.5.2 |  VTA structure
 Male MKP-2-/- and MKP-2+/+ mice (10-12 weeks old, n=6 for both genotypes) were perfused 
transcardially with 4% PFA. Brains were removed and post-fixed for 1 hour in 4% PFA, washed 
with PBS, followed by cryoprotection in 30% sucrose. Coronal brain sections (70μm) were 
prepared using a cryostat (Leica). Slices were rinsed with PBS and agitated in PBS with 0.5% 
Triton X-100 for 15 min. Free-floating sections were then pre-blocked for 1 hour at room 
temperature in PBS with 0.2% Triton X-100, 6% normal donkey serum (NDS; Jackson 
ImmunoResearch), and incubated overnight at 4°C with constant agitation in PBS with 0.2% 
Triton X-100, 2% NDS and chicken anti-TH monoclonal antibody (1:1000, Abcam, ab76442). 
Sections were then rinsed in PBS for 1 hour and incubated for 2 hours at room temperature with 
Alexa Fluor 488 goat anti-chicken antibody (1:1000, Life Technologies, UK) and DAPI 
(1:1000, Santa Cruz, USA). After subsequent rinses in PBS, sections were mounted on slides 
using Fluoromount Aqueous Mounting Medium (Sigma, UK) and visualised using a Leica SP5 
confocal laser scanning microscope.  Images were analysed using Fiji and the particle analyser 
plug-in. For each animal, 3 sections were selected for analysis containing rostral, middle and 
caudal parts of the VTA. For each section, three parts were imaged containing dorsal, middle 
and ventral parts of the parabrachial pigmented nucleus of the VTA.  Each section was scanned 
with a 20x objective with 5x zoom, to produce a 5μm thick scan (z = 1μm). Total cells (TH and 
DAPI) were counted for each scan, an average computed for each section and then for each 
animal (i.e., 9 scans per animal), which was then expressed as a density based on the volume 
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of the scanned region.  Immunohistochemistry and imaging were conducted blind to the 
experimental group.
2.6 |  Behavioural testing 
2.6.1 |  Amphetamine-induced hyperlocomotion 
Mice (n = 8 per genotype, 10-12 weeks old) were placed individually in the 40 x 40 x 40 cm 
black opaque Perspex XT open field arenas lit from below via infrared LED lighting for 30 
minutes habituation. Following habituation, each mouse received an intraperitoneal (i.p.) 
injection of D-amphetamine (3mg kg-1, Sigma-Aldrich), a dose that robustly induces 
hyperlocomotion in mice (Spielewoy et al., 2001; Papathanou et al., 2018). Mice were then 
placed back in the open field arenas and the distance moved was recorded for 60 minutes by an 
infrared camera (Sony) and Ethovision® XT software (Noldus, UK) for tracking spatial 
location of each mouse. The open field arena was cleaned and disinfected with Save4 odourless 
disinfectant (diluted 1:10) between each mouse. 
2.6.2 |  Sucrose preference test (SPT)
Before the test, each mouse (10-12 weeks old) was singly housed in an MB1 cage (NKP 
CAGES, overall size: 45 x 28 x 13 cm, internal size: 960 cm2 x 13 cm). Mice were presented 
with identical bottles of water and the amount of water consumed for each was measured daily 
in order to determine the preferred bottle position. For the next two days, mice were adapted to 
sucrose by replacing the water bottle in the non-preferred position with an identical bottle 
containing 1 % (w/v) sucrose solution. The 1% sucrose solution was freshly prepared by 
dilution of sucrose (Fisher, Scientific UK) with tap water, and the amount of water and sucrose 
consumed was measured daily. Following an adaptation period (3 days), the sucrose preference 
test was performed. The position of the two bottles (water and 1% sucrose solution) was 
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randomly determined to avoid a place preference. The amount of sucrose solution and water 
consumed was measured daily (between 09:00 and 10:00) across three consecutive days and 
the % sucrose intake calculated.
2.7 | Statistics 
All data are expressed as mean ± S.E.M. Shapiro-Wilk normality tests (supplementary Table 1) 
were undertaken for all data sets following which they were compared by paired or unpaired 
two-tailed Student’s t-tests or two-tailed Mann-Whitney U non-parametric tests, one-way 
analysis of variance with Tukey’s post-hoc correction or 2-way repeated-measures ANOVA 
followed by Bonferroni post-hoc correction as appropriate using GraphPad Prism (v5.0) or 
SigmaPlot (v12.0). Differences were considered significant when p < 0.05. 
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3 |  Results 
3.1 | Altered cerebral metabolism and regional functional connectivity in 
MKP-2-/- mice 
LCGU was significantly and selectively increased in the VTA of MKP-2-/- mice (t(19)=2.103, 
p=0.049, n = 11, Figure 1a) when compared to MKP-2+/+ control mice (n = 10). In all other (52) 
brain regions analysed, LCGU was not significantly altered in MKP-2-/- mice (Figure 1b & c, 
Table 1). The functional connectivity of the VTA to other brain regions was markedly altered 
in MKP-2-/- mice, with both increases and decreases in connectivity identified on a region-
dependent basis (Figure 1b, Table 2). In this way, VTA connectivity to the nucleus accumbens 
shell (NacS), hippocampus (HC, dorsal hippocampus CA1 [DH-CA1] and ventral hippocampus 
dorsal subiculum [VH-DS]), the basolateral amygdala (BLA) and the median raphé (MR) was 
significantly reduced in MKP-2-/- mice. In contrast, the VTA showed increased functional 
connectivity to multiple components of the basal ganglia (ventromedial striatum [VMST], 
substantia nigra pars compacta [SNC] and the globus pallidus [GP]), and to the prelimbic cortex 
(PrL) in MKP-2-/- mice compared to MKP-2+/+ mice (Figure 1b, Table 2).
3.2 | Increased sEPSC frequency onto VTA DA neurons in MKP-2-/- mice but 
neuronal excitability is unaltered. 
Based on the increased glucose uptake in the VTA of MKP-2-/- mice and our previous results 
from the hippocampus (Abdul Rahman et al., 2016), we examined whether increased excitatory 
synaptic transmission onto dopamine neurons is increased in MKP-2-/- mice. Thus, we 
examined neuronal excitability and synaptic transmission of VTA DA neurons in acute brain 
slices, with neuronal identity of all IH positive neurons confirmed post-experiment by co-
localisation of biocytin with TH (Figure 2a). IH amplitude was unaltered in VTA DA neurons 
(IH at -100 mV: MKP-2+/+, 118.3 ± 18.4 pA, n = 6; MKP-2-/-, 114.7 ± 28.4 pA, n = 6; Figure 
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2b-d) as was the number of action potentials fired  (200pA current injection: MKP-2+/+, 5.3 ± 
1.7, n = 4; MKP-2-/-, 4.5 ± 2.2, n = 4; t(6) = 0.268, p = 0.797)  and input resistance (-100pA 
current injection: MKP-2+/+: 572.5 ± 70.4 MΩ, n = 4; MKP-2-/-: 621.0 ± 117.6 MΩ, n = 4; t(6) 
= 0.356, p = 0.736) suggesting that the intrinsic firing properties of DA neurons in MKP-2-/- 
mice are unaltered.  However, there was a significant increase in the frequency (MKP-2+/+, 0.1 
± 0.1 Hz, n = 6; MKP-2-/-, 0.7 ± 0.2 Hz, n = 6; U = 5, p = 0.044; Figure 2g) but not amplitude 
(MKP-2+/+, 13.7 ± 1.1 pA, n = 6; MKP-2-/-, 14.3 ± 1.4 pA, n = 6; t(10) = 0.366, p = 0.722; 
Figure 2h) of sEPSCs onto VTA DA neurons in MKP-2-/- slices when compared with MKP-
2+/+ controls. 
3.3 |  Changes in VTA neuronal density do not underlie altered functional connectivity.
Having established altered cerebral metabolism and region-specific alterations in functional 
connectivity in MKP-2-/- mice compared to MKP-2+/+ controls, we next conducted 
immunohistochemistry using DAPI (a marker for cell nuclei) to examine cell density within the 
VTA. In addition, and given the prominent role of DA neurons in VTA function (Nair-Roberts 
et al., 2008; Creed et al., 2014; Walsh and Han, 2014), we also examined TH (the rate limiting 
enzyme in dopamine synthesis) to determine whether changes in the VTA neuronal density 
might be responsible for these findings in LCGU. Immunofluorescence indicated that the 
density of dopaminergic neurons (n = 6 for each genotype; t(10) = 0.957, p = 0.361), the density 
of all nuclei (n = 6 for each genotype; t(10) = 0.815, p = 0.434) and the ratio of dopaminergic 
neurons to all nuclei (n = 6 for each genotype; t(10) = 1.311, p = 0.219) in the VTA were 
unaltered in MKP-2-/- mice compared to MKP-2+/+ control mice (Figure 3a, b).  These results 
indicate that observed changes in VTA functional connectivity are unlikely to be due to 
differences in total cell number or the number of dopamine neurons.
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3.4 |  MKP-2 deletion alters reward processing.
Having established increased VTA function and altered connectivity in MKP-2-/- mice, we 
analysed their performance in relevant behavioural tests to determine if behaviours underpinned 
by these neural systems were altered. To investigate the function of the meso-corticolimbic 
dopamine system, we evaluated the behavioural sensitivity of MKP-2-/- mice to amphetamine 
(3mg kg-1, i.p.). Consistent with our previous findings (Abdul Rahman et al., 2016), the general 
locomotor activity in MKP-2-/- mice was unaffected compared to MKP-2+/+ control mice ( F(1,14) 
= 0.080, p = 0.782, n=8 for both genotypes, Figure 4a).  However, the amphetamine-induced 
hyperlocomotor response was significantly attenuated in MKP-2-/- compared to MKP-2+/+ 
control mice (F(1,14) = 7.435, p = 0.016, n=8 for both genotypes, Figure 4a). We further 
investigated whether sucrose preference, a measure of reward processing and hedonic state, 
was altered in MKP-2-/- mice.  Over a 3-day testing period, sucrose intake in MKP-2-/- mice was 
significantly increased on days 2 and 3 in MKP-2-/- mice compared to MKP-2+/+ control mice 
(genotype effect: F(1,28) = 8.385, p = 0.007; no effect of time: F(2,28) = 2.158, p = 0.125, no 
interaction: F(2,28) = 0.256, p = 0.772; n=16 for both genotypes, Figure 4b). 
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4 |  DISCUSSION
In the present study, we used an unbiased whole brain approach using MKP-2-/- mice to assess 
how MKP-2 deficiency impacts on brain function. We found that MKP-2 deletion results in a 
selective increase in VTA metabolism, as evidenced by local glucose utilisation, and altered 
functional connectivity of the VTA to diverse neural systems.  Guided by these data, we 
undertook targeted characterisation of the VTA in MKP2-/- mice. We found that MKP-2 
deletion did not alter VTA neuronal density or the intrinsic electrophysiological properties of 
VTA DA neurons, but increased glutamatergic synaptic activity onto VTA DA neurons was 
evident.  Furthermore, we confirmed that MKP-2-/- mice exhibited behavioural deficits relevant 
to the VTA dysfunction identified, including reduced amphetamine-induced hyperlocomotion 
and increased sucrose preference.
4.1 |  Increased VTA metabolism and functional connectivity in MKP-2-/- mice.
14C-2-DG autoradiographic imaging has been used to identify localised changes in brain 
metabolism in numerous studies (Dawson et al., 2012, 2013). Recently, studies have utilised 
mathematical algorithms to investigate alterations in connectivity between brain regions using 
14C-2-DG data (Dawson et al., 2012, 2013, 2015). As MAPK pathways have diverse roles 
within the CNS, we examined whether MKP-2 deletion led to alterations in metabolism in 
discrete brain regions and disrupted functional brain connectivity. Our 14C-2-DG data indicates 
that LCGU is significantly and selectively increased in the VTA of MKP-2-/- mice and that its 
functional connectivity is altered in a region-specific manner. This includes altered functional 
connectivity between the VTA and subfields of the prefrontal cortex, striatum, and the 
hippocampus (Figure 1, Tables 1 & 2), which is consistent with our previous observation of 
altered hippocampal-dependent spatial learning in these mice (Abdul Rahman et al., 2016). The 
mesolimbic system is established as an essential component of the reward system with the VTA 
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and NAc playing critical roles in reward processing (Cohen et al., 2012; Creed and Lüscher, 
2013), with altered reward processing being associated with alterations in MAPK activity (Jia 
et al., 2013; Ciccarelli and Giustetto, 2014). Given our understanding of VTA function and our 
observations regarding increased VTA metabolism and altered functional connectivity in MKP-
2-/- mice, we hypothesised that these alterations would lead to changes in relevant behavioural 
tests, including tests characterising reward processing.
4.2 |  sEPSC frequency onto VTA dopaminergic neurons is increased in MKP-2-/- mice.
Having established that MKP-2 deletion leads to changes in VTA metabolism and functional 
connectivity, we next examined the alterations in VTA neuronal excitability and synaptic 
activity underlying these observations. An increase in sEPSC frequency, but not amplitude, 
onto IH positive VTA neurons in MKP-2-/- mice was observed, indicating that presynaptic 
functional changes result in enhanced glutamate release. This increased excitatory drive may 
contribute to the increased VTA metabolism observed in these mice. However, the exact 
mechanisms that underlie this increased sEPSC frequency remain elusive. One possibility is 
that ERK activity is increased presynaptically in the absence of MKP-2, which would lead to 
changes in presynaptic release machinery and/or the number of docked vesicles (Kushner, 
2005; Giachello et al., 2010). This finding may account for the increased sEPSC frequency 
observed in the present study. However, given that ERK activity has previously been shown to 
be unaltered in MKP-2-/- mice when examined in tissue from various brain regions (Abdul 
Rahman et al., 2016), whether presynaptically localised changes in ERK activity in the VTA 
accounts for this remains unknown. To date ERK activity in synapses onto VTA neurons has 
not yet been characterised in MKP-2-/- mice, so the possibility of a selective increase in this 
region remains a possibility that certainly warrants further investigation. Additionally, it should 
also be noted that whilst the VTA contains a heterogeneous population of neuronal types 
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including dopaminergic, GABAergic and glutamatergic neurons (Nair-Roberts et al., 2008; 
Creed et al., 2014; Morales and Root, 2014; Walsh and Han, 2014), here we have focussed on 
glutamatergic synaptic activity onto VTA DA neurons. Hence, it would be interesting to 
characterise the synaptic activity onto other identified neuronal subtypes within the VTA. 
Strikingly, increased synaptic connectivity in the VTA is observed following injections of 
rewarding drugs of abuse (Ungless et al., 2001; Oliva and Wanat, 2016; Francis et al., 2018), 
with these drug-induced increases in synaptic strength being primarily mediated by 
postsynaptic changes.  In contrast, the classic interpretation of our findings in relation to 
increased sEPSC frequency but not amplitude, are that these changes are mediated 
presynaptically. This suggestion is also consistent with the observation that 14C-2-DG and 
glucose metabolism largely reflects local synaptic activity in the brain region of interest. 
However, it would be interesting to further characterise the functional basis of the increased 
sEPSCs seen in the VTA of MKP2-/- mice using paired pulse facilitation and AMPA/NMDA 
ratio paradigms in order to identify the exact locus of increased sEPSC frequency.  
4.3 |  Altered VTA function  is not due to structural changes in MKP-2-/- mice.
Having established that MKP-2 deletion leads to changes in VTA function, we examined 
whether structural changes within the VTA accounted for these observations. We found that 
the density of dopaminergic neurons, the density of all nuclei, and the ratio of dopaminergic 
neurons to all nuclei were not altered in MKP-2-/- mice, indicating that VTA structural changes 
do not underlie our observations of altered VTA metabolism and functional connectivity in 
these animals. This raises the question as to the nature of the physiological changes within the 
VTA that underlie our observations, and generally rules out the contribution of gross cellular 
neurodevelopmental alterations as the primary mechanism underlying VTA dysfunction in 
MKP-2-/- mice. However, at present it is still unclear as to whether altered VTA metabolism 
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and connectivity in MKP-2-/- mice is mediated by more subtle development effects, for example 
through effects on neuronal differentiation (Kim et al., 2015), or whether the effect of a lifelong 
loss of MKP-2 function can be reversed by acutely rescuing VTA MKP-2 function in these 
animals. While our observation that VTA dopaminergic neuronal density is not altered in MKP-
2-/- mice is suggestive that reduced VTA LCGU is not mediated by developmental proliferation 
defects, at least for DA neurons, this potential mechanism requires further investigation and the 
impact on other neuronal cell types still remains as a plausible contributory mechanism.
4.4 |  Impaired amphetamine-induced locomotor activity but increased sucrose preference 
in MKP-2-/- mice.
Since it is well established that rewarding drugs of abuse modulate synaptic transmission and 
plasticity onto the dopaminergic VTA neurons (Ungless et al., 2001; Oliva and Wanat, 2016; 
Francis et al., 2018) and we observed synaptic dysfunction in the VTA of these animals, we 
investigated the effect of amphetamine injection in MKP-2-/- mice using the open field test. 
Surprisingly, locomotor activity was decreased in MKP-2-/- mice injected with amphetamine 
compared with that observed in MKP-2+/+ mice. There is much debate regarding the brain 
regions and mechanisms involved in psychostimulant-induced behaviour and addiction but 
altered VTA connectivity is strongly implicated  (Hyman and Malenka, 2001; Morales and 
Margolis, 2017). In particular, it is well established that psychostimulant drugs, including 
amphetamine, result in increased extracellular DA levels that contribute to the resultant 
hyperlocomotion (Heshmati and Russo, 2015; Morales and Margolis, 2017). Indeed, recent 
studies have proposed a key role for VGLUT2 containing VTA DA neuronal connectivity with 
the NAc in psychostimulant-induced behaviour and hyperlocomotion (Birgner et al., 2010; 
Hnasko et al., 2010; Fortin et al., 2012; Papathanou et al., 2018).  The similarity between these 
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findings and our own in regard to impaired response to amphetamine and the reduced VTA-
NAc functional connectivity seen in MKP-2-/- mice is intriguing and warrants further work.
To examine whether the mesolimbic system dysfunction seen in MKP-2-/- mice results in 
alterations in reward processing, we used the sucrose preference test, an established method for 
investigating hedonic state. Consistent with an increase in VTA LCGU metabolism, MKP-2-/- 
mice displayed a greater preference for sucrose than MKP-2+/+ mice. In agreement with our 
findings, previous studies have revealed that optogenetic inhibition of VTA dopaminergic 
neurons leads to decreased sucrose preference in mice (Cohen et al., 2012; Nieh et al., 2015). 
Furthermore, increased VTA activity is associated with increased reward seeking behaviour 
(Kempadoo et al., 2013; Creed et al., 2014) and our observations of altered hippocampal-VTA-
accumbens functional connectivity in MKP-2-/- mice are consistent with the established role of 
this neural circuit in reward processing and novelty detection (Lisman and Grace, 2005; 
Morales and Margolis, 2017). Hence, this may also contribute to the altered sucrose preference 
seen in these animals.  Intriguingly, these data suggest that the decreased expression of MKP-
2 seen in the brains of patients with depression (Dwivedi et al., 2001) and schizophrenia 
(Kyosseva et al., 1999), may contribute to the anhedonia seen in these disorders, which may be 
mediated, in part, by the influence of MKP-2 on the VTA and mesolimbic reward system 
function. Clearly, further studies are required to elucidate the potential role of MKP-2 
dysfunction in the aetiology of these disorders and MKP-2’s potential contribution to altered 
reward processing and motivation.
Our data reveal contrasting results between increased preference for the natural reward of 
sucrose compared to the drug-induced effects of amphetamine. Whilst a clear rationale for this 
is unknown, it is generally accepted that amphetamine-induced hyperlocomotion is a selective 
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challenge of the dopaminergic system and reflects increased DA levels in mesolimbic regions, 
whereas sucrose preference is proposed to engage several neuronal circuits/systems (Heshmati 
and Russo, 2015; Morales and Margolis, 2017). These contrasting results could be examined 
further through targeted deletion of VTA MKP-2 in wild-type mice that would allow normal 
development and the determination of the acute effects of MKP-2 signalling, or via targeted 
MKP-2 reintroduction into the VTA of MKP-2-/- mice in order to rescue the phenotypes 
observed here. However, these experiments are clearly beyond the scope if this initial unbiased 
whole brain approach.
Taken together, the present study reveals a novel role for MKP-2 in reward processing 
paralleled by concomitant changes in VTA function and functional connectivity.  These 
findings indicate that MKP-2 may play role in the altered reward processing that occurs in CNS 
disorders associated with MKP-2 dysfunction, particularly those in which altered reward 
processing is prominent. 
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Figure Captions
Figure 1. Altered VTA metabolism and functional connectivity in MKP-2-/- mice. (a) LCGU is 
selectively increased in the VTA of MKP-2-/- mice (n = 11) compared to MKP-2+/+ control mice 
(n = 10) but not in (b) the ventral hippocampal CA1 region or (c) the central amygdala. (d-i) 
Summary statistical diagrams showing altered VTA functional connectivity in MKP-2-/- mice. 
Brain section figures are modified from the Allen mouse brain atlas (http://mouse.brain-
map.org/static/atlas). Blue denotes regions that have significantly lost functional connectivity 
with the VTA in MKP-2-/- mice. Red denotes regions that show significantly gained functional 
connectivity to the VTA in MKP-2-/- but not MKP-2+/+ mice. Yellow highlights the anatomical 
localisation of the VTA. (j) The functional connectivity heatmap also shows the lost (blue) and 
gained (red) alterations in VTA functional connectivity in MKP2-/- mice. Amyg. = Amygdala, 
Dorsal Hip.= Dorsal Hippocampus, Ventral Hip.= Ventral Hippocampus, Aud. = Auditory 
System, Multi.= Mutlimodal regions. Regional abbreviations and their systems are shown in 
Table 1. Differences in LCGU between groups was analysed using unpaired two-tailed 
Student’s t-test with * p < 0.05 vs MKP-2+/+ controls. Full LCGU and functional connectivity 
data are shown in Tables 1 and 2 respectively.
Figure 2. Increased sEPSC frequency onto VTA DA neurons in MKP-2-/- mice. (a)  
Representative images and traces of co-localisation of biocytin (magenta) filled IH positive 
neuron and tyrosine hydroxylase (TH; green) in the VTA. (b-c) Representative IH traces 
recorded from MKP-2+/+ and MKP-2-/- VTA neurons respectively. (d) IH amplitude is unaffected 
in VTA DA neurons from MKP-2-/- mice when compared to MKP-2+/+ controls (n = 6). (e-f)  
Representative sEPSC traces from MKP+/+ and MKP-/- mice respectively. (g) sEPSC frequency 
is increased in MKP-2-/- slices (n = 6) compared to MKP+/+ slices (n = 6) whereas (h) sEPSC 
amplitude is unchanged. Data were analysed using 2-way repeated-measures ANOVA followed 
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by Bonferroni post-hoc correction (IH) and two-tailed Mann-Whitney U non-parametric tests 
(sEPSCs) with * p < 0.05 vs MKP-2+/+ controls. N is equal to one neuron per slice per animal 
with all IH positive neurons confirmed to be DA neurons (TH positive) post experiment.
Figure 3. No change in dopamine neuron number in MKP-2-/- mice. (a) Immunostaining for 
tyrosine hydroxylase (TH; green) and DAPI (blue) appeared normal in MKP-2-/- mice (n = 6) 
compared to MKP-2+/+ control mice (n=6). (b) Quantitative analyses revealed no significant 
differences between the densities of dopaminergic (TH+ve) neurons, total cell bodies (DAPI) 
and the ratio of TH / total cells in MKP-2-/- mice compared to MKP-2+/+ control mice. Data 
analysed using unpaired two-tailed Student’s t-tests.
Figure 4. Reduced amphetamine-induced hyperlocomotion but increased sucrose preference 
in MKP-2-/- mice. (a) Amphetamine (3mg kg-1, i.p.)-induced hyperlocomotion is significantly 
attenuated in MKP-2-/- mice (n=8 for both genotypes). (b) Sucrose intake (1% solution) in 
relation to total fluid intake is significantly increased in MKP-2-/- mice compared to MKP-2+/+ 
mice on trial days 2 and 3 (n=16 for both genotypes). Both sets of data were analysed using 2-
way repeated-measures ANOVA followed by Bonferroni post-hoc correction with * p < 0.05 
vs MKP-2+/+ controls.
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ABSTRACT
Mitogen-activated protein kinases (MAPKs) regulate normal brain functioning and their 
dysfunction is implicated in a number of brain disorders. Thus, there is great interest in 
understanding the signalling systems that control MAPK functioning. One family of proteins 
that contribute to this process, the mitogen-activated protein kinase phosphatases (MKPs), 
directly inactivate MAPKs through dephosphorylation. Recent studies have identified novel 
functions of MKPs in foetal development, the immune system, cancer and synaptic plasticity 
and memory. In the present study, we performed an unbiased investigation using MKP-2-/- mice 
to assess whether MKP-2 plays a global role in modulating brain function.  Local cerebral 
glucose utilization is significantly increased in the ventral tegmental area (VTA) of                
MKP-2-/- mice, with connectivity analysis revealing alterations in VTA functional connectivity, 
including a significant reduction in connectivity to the nucleus accumbens and hippocampus. 
In addition, spontaneous excitatory postsynaptic current frequency, but not amplitude, onto 
putative dopamine neurons in the VTA is increased in MKP-2-/- mice, which indicates that 
increased excitatory drive may account for the increased VTA glucose utilization. Consistent 
with modified VTA function and connectivity, in behavioural tests MKP-2-/- mice exhibited 
increased sucrose preference and impaired amphetamine-induced hyperlocomotion. Overall, 
these data reveal that MKP-2 plays a role in modulating VTA function and that its dysfunction 
may contribute to brain disorders in which altered reward processing is present. 




ACSF - artificial cerebrospinal fluid
BDNF - brain-derived neurotrophic factor
BSA - bovine serum albumin 
CNS - central nervous system
DA - dopamine
DUSP - dual-specificity phosphatases
ERK - extracellular signal related kinase
FBS - fetal bovine serum 
JNK - c-jun N-terminal kinase
LCGU - local cerebral glucose utilization
MAPK - mitogen-activated protein kinase
MKP - mitogen-activated protein kinase phosphatase
NDS – normal donkey serum
PLSR - partial least squares regression algorithm
PBS - phosphate-buffered saline
PFA - paraformaldehyde  
RoI - region of interest
sEPSC - spontaneous excitatory postsynaptic current
SPT - sucrose preference test
TH - tyrosine hydroxylase
VIP - variable importance to the projection
VTA - ventral tegmental area
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1 |  INTRODUCTION
The mitogen-activated protein kinases (MAPK) form a family of evolutionally conserved 
proteins, which play a critical role in various cellular processes including cellular proliferation, 
differentiation, development, transformation and apoptosis (Keshet and Seger, 2010). The 
mammalian MAPK family consists of the extracellular signal related kinase (ERK), the c-jun 
N-terminal kinase (JNK) and p38 MAPK. MAPK signalling shares a common three-tiered core 
structure, where the activation of MAPK requires sequential phosphorylation and activation of 
each component kinase. The activated MAPKs then convert the extracellular stimuli into a 
broad range of cellular responses. In the central nervous system (CNS), MAPKs are expressed 
in numerous cell types, where they play a role in the regulation of synaptic transmission and 
plasticity (Thomas and Huganir, 2004; Samuels et al., 2009). In addition, their dysfunction has 
been implicated in CNS disorders including Alzheimer’s disease, autism, Parkinson’s disease, 
anxiety and addiction (Yasuda et al., 2011; Lee & Kim, 2017; Vithayathil et al., 2018). 
 
The duration and magnitude of MAPK activation are crucial in determining the physiological 
outcome of this signalling pathway (Marshall, 1995; Caunt & Keyse, 2013). Thus, the negative 
regulation of phosphorylation process is vital for controlling MAPK signalling. The process of 
MAPK inactivation is mediated by the family of dual-specificity phosphatases (DUSPs), the 
mitogen-activated protein kinase phosphatases (MKPs), which catalyse the dephosphorylation 
of MAPK that consequently leads to inhibiting their activity. However, our knowledge of MKP 
function in the CNS is limited but studies suggest a role for the prototypic Dusp1 (MKP-1) in 
brain-derived neurotrophic factor (BDNF)-induced axonal branching (Jeanneteau et al., 2010) 
and depression (Duric et al., 2010; Chen et al., 2012; Jia et al., 2013; Hui et al., 2016; Barthas 
et al., 2017). In contrast, the role of Dusp4 (MKP-2) in the CNS has not been studied 
extensively. However, we have recently shown that Dusp4 deletion increases hippocampal 
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spontaneous excitatory postsynaptic potential (sEPSC) frequency as well as impairing spatial 
reference and working memory (Abdul Rahman et al., 2016). 
Building on our previous findings and given our limited knowledge of MKP-2 function in the 
CNS, we performed an unbiased investigation using MKP-2-/- mice to examine the consequence 
of Dusp4 gene deletion on brain function and behaviour.
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2 |  MATERIALS AND METHODS
2.1 |  Animals 
All in vivo experimental procedures were in accordance with UK legislation (Animals 
(Scientific Procedures) Act 1986) and with approval by the University of Strathclyde Ethics 
Committee. All experiments were completed using male MKP-2+/+ and MKP-2-/- mice 
generated as previously described (Al-Mutairi et al., 2010), normally group-housed (5–6 per 
cage) under standard conditions (21°C, 45%–65% humidity, 12h dark/light cycle [lights on 
06:00]) in cages provided with environmental enrichment in the form of a plastic refuge and 
nesting material. Animals had free access to food and water with all behavioural procedures 
carried out between 09.00 and 17.00. Mice were randomly assigned to the treatment groups 
with the experimenter blinded to each group. 
2.2 | 14C-2-Deoxyglucose (14C-2-DG) functional brain imaging 
Local cerebral glucose utilization (LCGU) was determined in MKP-2-/- (n = 11) and MKP- 2+/+ 
(n = 10) mice (10-12 weeks old) in accordance with previously published protocols , using an 
approach adapted from the original protocol developed in rats (Sokoloff et al., 1977) for 
application in conscious freely-moving mice (Dawson et al., 2011, 2013). In brief, LCGU 
measurement was initiated by injection of 14C-2-DG (intraperitoneally (i.p.), 4.625 MBq/kg in 
physiological saline at 2.5ml/kg (Perkin-Elmer, UK) and animals were returned to their home 
cage. Forty five minutes after 14C-2-DG injection animals were decapitated and a terminal 
blood sample collected, by torso inversion, into heparinized weigh boats. Plasma glucose 
concentrations (mmol/L) were detected from whole blood using a blood glucose monitor 
(Accu-Chek Aviva). The brain was then rapidly dissected out intact, frozen in isopentane (-
40oC) and stored at (-80oC) until sectioning. Blood samples were centrifuged to isolate plasma, 
and plasma 14C concentrations (20μl) were determine by liquid scintillation analysis (Packard). 
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Frozen brains were sectioned (20μm) in the coronal plane in a cryostat (-20oC). A series of 
three consecutive sections were retained from every 60μm, thaw mounted onto slide covers and 
rapidly dried on a hotplate (70oC). Autoradiograms were generated by apposing these sections, 
together with precalibrated 14C standards (39-1098 nCi/g tissue equivalents, Amersham 
International, UK) to x-ray film (Carestream BioMax MR film, Sigma-Aldrich, UK) for 7 days. 
Autoradiographic images were analysed by a computer based image analysis system 
(MCID/M5+, Interfocus, UK). The local isotope concentration for each brain region of interest 
(RoI) was derived from the optical density of the autoradiographic images relative to that of the 
coexposed 14C standards, with 8-12 replicate measurements taken per RoI in each animal. 
LCGU was determined in 53 anatomically distinct brain RoI as the ratio of 14C present in that 
region relative to the average 14C-2-DG concentration in the whole brain of the same animal, 
referred to as the 14C-2-DG uptake ratio. There was no significant difference between the whole 
brain average 14C-2-DG concentration in MKP-2-/- mice relative to wild-type controls (MKP-
2+/+ 142.05 ± 7.74 nCi/g; MKP-2-/- 164.80 ± 8.27 nCi/g, p=0.103 Student’s t-test), suggesting 
that MKP-2 deletion did not significantly impact global cerebral metabolism. In addition, there 
was no significant difference in plasma 14C-2-DG levels (MKP-2+/+ 22.9 ± 1.58 nCi/ml, MKP-2-
/- 29.21 ± 3.33 nCi/ml, p=0.115 Student’s t-test) or glucose levels (MKP-2+/+ 9.00 ± 0.35 
mmol/L, MKP-2-/- 8.28 ± 0.46 mmol/L, p=0.224 Student’s t-test) between the two experimental 
groups, suggesting that there were no systematic difference in plasma glucose or 14C-2-DG 
concentrations between the two experimental groups that might impact on LCGU measurement.
2.3 |  Functional brain connectivity analysis using PLSR 
The partial least squares regression algorithm (PLSR) was employed to define significant 
differences in the functional connectivity of selected “seed” RoI to all other RoI analysed from 
the functional 14C-2-DG brain imaging data, as previously outlined (Dawson et al., 2012, 2013; 
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Hughes et al., 2019), and was undertaken using the PLS package (Mevik and Wehrens, 2007) 
in R (R Core Team, 2018). The analysed “seed” brain RoI were those regions in which a 
significant alteration in overt LCGU was observed, namely the ventral tegmental area (VTA, 
Figure 1). In brief, functional connectivity between the “seed” RoI and all other RoI analysed 
was defined by the variable importance to the projection (VIP) statistic gained from the PLSR 
models. A region was considered to be functionally connected to the “seed” region if the 95% 
confidence interval (95% CI) of the VIP statistic exceeded 0.8. This denotes a considerable 
contribution of the explanatory variable (RoI metabolism) to the dependent variable (“seed” 
RoI metabolism) in PLSR models. The standard deviation (SD) and 95% CI of the VIP statistic 
were estimated by jack-knifing. Significant differences in the VIP statistic between groups were 
analysed using t-test with Bonferroni post-hoc correction for multiple comparisons on the basis 
of the number of potentially connected RoI (52). Thus genotype-induced alterations in regional 
functional connectivity to the VTA were defined in terms of lost (VIP 95% CI >0.8 in MKP-
2+/+ mice, VIP 95% CI <0.8 in MKP-2+/- mice and p<0.05 significant difference between 
genotypes) and abnormally gained (VIP 95% CI <0.8 in MKP-2+/+ mice, VIP 95% CI >0.8 in 
MKP-2+/- mice and p<0.05 significant difference between genotypes) connectivity in MKP-2-/- 
mice.
2.4 |  Electrophysiology 
Mice (19–25 days old) were killed by cervical dislocation and decapitated. The brains were 
rapidly removed and placed immediately in an ice-cold (0–3°C), oxygenated (95% O2/5% CO2) 
artificial cerebrospinal fluid (ACSF) containing (in mM): 124 NaCl, 3 KCl, 26 NaHCO3, 2.5 
NaH2PO4, 2 MgSO4, 2 CaCl2, 10 glucose. Horizontal slices (230 μm) were cut using a 
vibratome and transferred to a holding chamber containing oxygenated ACSF, equilibrated at 
37oC for 30 min followed for 30 min at the room temperature prior to recording. Slices were 
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then transferred into a submerged recording chamber continuously perfused with ACSF at a 
flow rate at 2-3 mL min-1 at room temperature. Electrodes (4-7 MΩ) were filled with an internal 
solution containing (in mM): 130 KMeSO4, 20 KCl, 4 Mg-ATP, 0.4 Na-GTP, 0.5 EGTA, 10 
HEPES, 0.5% (w/v) biocytin, pH 7.2, 290 mOsm. Visually-guided whole-cell patch-clamp 
recordings were made from neurons in the VTA using an Axopatch 200B amplifier (Molecular 
Devices, USA), connected to a personal computer interfaced with Digidata 1322A interface 
(Molecular Devices, USA) and captured using pClamp9.0 software (Molecular Devices, USA). 
Spontaneous EPSCs were recorded at -70mV for 5 min periods, digitized at 5kHz. For IH 
recordings, cells were held at -70mV in voltage clamp mode with -10mV increments at 10s 
intervals. Data were analysed offline using pClamp9.2 software (Molecular Devices, USA) or 
MiniAnalysis software (Synaptosoft, USA). For all slice experiments, n is equal to one neuron 
per slice per animal with all IH positive neurons confirmed to be dopaminergic (DAergic) 
neurons post experiment using immunohistochemistry (see below).
2.5 |  Immunohistochemistry
2.5.1 |  Confirmation of VTA dopamine (DA) neuron identity
Immediately following electrophysiological experiments, each slice was fixed in 4% 
paraformaldehyde (PFA) for 1 h, then washed with phosphate-buffered saline (PBS).  Slices 
were then agitated in PBS with 1% Triton X-100 for 1 h. Free-floating slices were then pre-
blocked for 1 h at room temperature in PBS with 0.5% Triton X-100, 1% (w/v) bovine serum 
albumin (BSA) and 5% (v/v) fetal bovine serum (FBS) and incubated overnight at 4°C with 
chicken polyclonal anti-tyrosine hydroxylase (TH) antibody (1:500, Abcam, ab76442) with 
0.5% Triton X-100, 1% (w/v) BSA and 5% (v/v) FBS. Slices were rinsed in PBS and incubated 
for 3 h with goat anti-chicken Alexa FluorTM 555 (1:200, Life Technologies, A21437) and 
streptavidin-Alexa FluorTM 488 (1: 500, Life Technologies, S11223) with 0.5% Triton X-100, 
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1% (w/v) BSA and 5% (v/v) FBS. After subsequent PBS rinses, slices were mounted on slides 
using Vectashield anti-fade mounting medium with DAPI (Vector Laboratories) and visualized 
using a Leica SP5 confocal laser-scanning microscope. 
2.5.2 |  VTA structure
 Male MKP-2-/- and MKP-2+/+ mice (10-12 weeks old, n=6 for both genotypes) were perfused 
transcardially with 4% PFA. Brains were removed and post-fixed for 1 hour in 4% PFA, washed 
with PBS, followed by cryoprotection in 30% sucrose. Coronal brain sections (70μm) were 
prepared using a cryostat (Leica). Slices were rinsed with PBS and agitated in PBS with 0.5% 
Triton X-100 for 15 min. Free-floating sections were then pre-blocked for 1 hour at room 
temperature in PBS with 0.2% Triton X-100, 6% normal donkey serum (NDS; Jackson 
ImmunoResearch), and incubated overnight at 4°C with constant agitation in PBS with 0.2% 
Triton X-100, 2% NDS and chicken anti-TH monoclonal antibody (1:1000, Abcam, ab76442). 
Sections were then rinsed in PBS for 1 hour and incubated for 2 hours at room temperature with 
Alexa Fluor 488 goat anti-chicken antibody (1:1000, Life Technologies, UK) and DAPI 
(1:1000, Santa Cruz, USA). After subsequent rinses in PBS, sections were mounted on slides 
using Fluoromount Aqueous Mounting Medium (Sigma, UK) and visualised using a Leica SP5 
confocal laser scanning microscope.  Images were analysed using Fiji and the particle analyser 
plug-in. For each animal, 3 sections were selected for analysis containing rostral, middle and 
caudal parts of the VTA. For each section, three parts were imaged containing dorsal, middle 
and ventral parts of the parabrachial pigmented nucleus of the VTA.  Each section was scanned 
with a 20x objective with 5x zoom, to produce a 5μm thick scan (z = 1μm). Total cells (TH and 
DAPI) were counted for each scan, an average computed for each section and then for each 
animal (i.e., 9 scans per animal), which was then expressed as a density based on the volume 
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of the scanned region.  Immunohistochemistry and imaging were conducted blind to the 
experimental group.
2.6 |  Behavioural testing 
2.6.1 |  Amphetamine-induced hyperlocomotion 
Mice (n = 8 per genotype, 10-12 weeks old) were placed individually in the 40 x 40 x 40 cm 
black opaque Perspex XT open field arenas lit from below via infrared LED lighting for 30 
minutes habituation. Following habituation, each mouse received an intraperitoneal (i.p.) 
injection of D-amphetamine (3mg kg-1, Sigma-Aldrich), a dose that robustly induces 
hyperlocomotion in mice (Spielewoy et al., 2001; Papathanou et al., 2018). Mice were then 
placed back in the open field arenas and the distance moved was recorded for 60 minutes by an 
infrared camera (Sony) and Ethovision® XT software (Noldus, UK) for tracking spatial 
location of each mouse. The open field arena was cleaned and disinfected with Save4 odourless 
disinfectant (diluted 1:10) between each mouse. 
2.6.2 |  Sucrose preference test (SPT)
Before the test, each mouse (10-12 weeks old) was singly housed in an MB1 cage (NKP 
CAGES, overall size: 45 x 28 x 13 cm, internal size: 960 cm2 x 13 cm). Mice were presented 
with identical bottles of water and the amount of water consumed for each was measured daily 
in order to determine the preferred bottle position. For the next two days, mice were adapted to 
sucrose by replacing the water bottle in the non-preferred position with an identical bottle 
containing 1 % (w/v) sucrose solution. The 1% sucrose solution was freshly prepared by 
dilution of sucrose (Fisher, Scientific UK) with tap water, and the amount of water and sucrose 
consumed was measured daily. Following an adaptation period (3 days), the sucrose preference 
test was performed. The position of the two bottles (water and 1% sucrose solution) was 
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randomly determined to avoid a place preference. The amount of sucrose solution and water 
consumed was measured daily (between 09:00 and 10:00) across three consecutive days and 
the % sucrose intake calculated.
2.7 | Statistics 
All data are expressed as mean ± S.E.M. Shapiro-Wilk normality tests (supplementary Table 1) 
were undertaken for all data sets following which they were compared by paired or unpaired 
two-tailed Student’s t-tests or two-tailed Mann-Whitney U non-parametric tests, one-way 
analysis of variance with Tukey’s post-hoc correction or 2-way repeated-measures ANOVA 
followed by Bonferroni post-hoc correction as appropriate using GraphPad Prism (v5.0) or 
SigmaPlot (v12.0). Differences were considered significant when p < 0.05. 
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3 |  Results 
3.1 | Altered cerebral metabolism and regional functional connectivity in 
MKP-2-/- mice 
LCGU was significantly and selectively increased in the VTA of MKP-2-/- mice (t(19)=2.103, 
p=0.049, n = 11, Figure 1a) when compared to MKP-2+/+ control mice (n = 10). In all other (52) 
brain regions analysed, LCGU was not significantly altered in MKP-2-/- mice (Figure 1b & c, 
Table 1). The functional connectivity of the VTA to other brain regions was markedly altered 
in MKP-2-/- mice, with both increases and decreases in connectivity identified on a region-
dependent basis (Figure 1b, Table 2). In this way, VTA connectivity to the nucleus accumbens 
shell (NacS), hippocampus (HC, dorsal hippocampus CA1 [DH-CA1] and ventral hippocampus 
dorsal subiculum [VH-DS]), the basolateral amygdala (BLA) and the median raphé (MR) was 
significantly reduced in MKP-2-/- mice. In contrast, the VTA showed increased functional 
connectivity to multiple components of the basal ganglia (ventromedial striatum [VMST], 
substantia nigra pars compacta [SNC] and the globus pallidus [GP]), and to the prelimbic cortex 
(PrL) in MKP-2-/- mice compared to MKP-2+/+ mice (Figure 1b, Table 2).
3.2 | Increased sEPSC frequency onto VTA DA neurons in MKP-2-/- mice but 
neuronal excitability is unaltered. 
Based on the increased glucose uptake in the VTA of MKP-2-/- mice and our previous results 
from the hippocampus (Abdul Rahman et al., 2016), we examined whether increased excitatory 
synaptic transmission onto dopamine neurons is increased in MKP-2-/- mice. Thus, we 
examined neuronal excitability and synaptic transmission of VTA DA neurons in acute brain 
slices, with neuronal identity of all IH positive neurons confirmed post-experiment by co-
localisation of biocytin with TH (Figure 2a). IH amplitude was unaltered in VTA DA neurons 
(IH at -100 mV: MKP-2+/+, 118.3 ± 18.4 pA, n = 6; MKP-2-/-, 114.7 ± 28.4 pA, n = 6; Figure 
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2b-d) as was the number of action potentials fired  (200pA current injection: MKP-2+/+, 5.3 ± 
1.7, n = 4; MKP-2-/-, 4.5 ± 2.2, n = 4; t(6) = 0.268, p = 0.797)  and input resistance (-100pA 
current injection: MKP-2+/+: 572.5 ± 70.4 MΩ, n = 4; MKP-2-/-: 621.0 ± 117.6 MΩ, n = 4; t(6) 
= 0.356, p = 0.736) suggesting that the intrinsic firing properties of DA neurons in MKP-2-/- 
mice are unaltered.  However, there was a significant increase in the frequency (MKP-2+/+, 0.1 
± 0.1 Hz, n = 6; MKP-2-/-, 0.7 ± 0.2 Hz, n = 6; U = 5, p = 0.044; Figure 2g) but not amplitude 
(MKP-2+/+, 13.7 ± 1.1 pA, n = 6; MKP-2-/-, 14.3 ± 1.4 pA, n = 6; t(10) = 0.366, p = 0.722; 
Figure 2h) of sEPSCs onto VTA DA neurons in MKP-2-/- slices when compared with MKP-
2+/+ controls. 
3.3 |  Changes in VTA neuronal density do not underlie altered functional connectivity.
Having established altered cerebral metabolism and region-specific alterations in functional 
connectivity in MKP-2-/- mice compared to MKP-2+/+ controls, we next conducted 
immunohistochemistry using DAPI (a marker for cell nuclei) to examine cell density within the 
VTA. In addition, and given the prominent role of DA neurons in VTA function (Nair-Roberts 
et al., 2008; Creed et al., 2014; Walsh and Han, 2014), we also examined TH (the rate limiting 
enzyme in dopamine synthesis) to determine whether changes in the VTA neuronal density 
might be responsible for these findings in LCGU. Immunofluorescence indicated that the 
density of dopaminergic neurons (n = 6 for each genotype; t(10) = 0.957, p = 0.361), the density 
of all nuclei (n = 6 for each genotype; t(10) = 0.815, p = 0.434) and the ratio of dopaminergic 
neurons to all nuclei (n = 6 for each genotype; t(10) = 1.311, p = 0.219) in the VTA were 
unaltered in MKP-2-/- mice compared to MKP-2+/+ control mice (Figure 3a, b).  These results 
indicate that observed changes in VTA functional connectivity are unlikely to be due to 
differences in total cell number or the number of dopamine neurons.
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3.4 |  MKP-2 deletion alters reward processing.
Having established increased VTA function and altered connectivity in MKP-2-/- mice, we 
analysed their performance in relevant behavioural tests to determine if behaviours underpinned 
by these neural systems were altered. To investigate the function of the meso-corticolimbic 
dopamine system, we evaluated the behavioural sensitivity of MKP-2-/- mice to amphetamine 
(3mg kg-1, i.p.). Consistent with our previous findings (Abdul Rahman et al., 2016), the general 
locomotor activity in MKP-2-/- mice was unaffected compared to MKP-2+/+ control mice ( F(1,14) 
= 0.080, p = 0.782, n=8 for both genotypes, Figure 4a).  However, the amphetamine-induced 
hyperlocomotor response was significantly attenuated in MKP-2-/- compared to MKP-2+/+ 
control mice (F(1,14) = 7.435, p = 0.016, n=8 for both genotypes, Figure 4a). We further 
investigated whether sucrose preference, a measure of reward processing and hedonic state, 
was altered in MKP-2-/- mice.  Over a 3-day testing period, sucrose intake in MKP-2-/- mice was 
significantly increased on days 2 and 3 in MKP-2-/- mice compared to MKP-2+/+ control mice 
(genotype effect: F(1,28) = 8.385, p = 0.007; no effect of time: F(2,28) = 2.158, p = 0.125, no 
interaction: F(2,28) = 0.256, p = 0.772; n=16 for both genotypes, Figure 4b). 
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4 |  DISCUSSION
In the present study, we used an unbiased whole brain approach using MKP-2-/- mice to assess 
how MKP-2 deficiency impacts on brain function. We found that MKP-2 deletion results in a 
selective increase in VTA metabolism, as evidenced by local glucose utilisation, and altered 
functional connectivity of the VTA to diverse neural systems.  Guided by these data, we 
undertook targeted characterisation of the VTA in MKP2-/- mice. We found that MKP-2 
deletion did not alter VTA neuronal density or the intrinsic electrophysiological properties of 
VTA DA neurons, but increased glutamatergic synaptic activity onto VTA DA neurons was 
evident.  Furthermore, we confirmed that MKP-2-/- mice exhibited behavioural deficits relevant 
to the VTA dysfunction identified, including reduced amphetamine-induced hyperlocomotion 
and increased sucrose preference.
4.1 |  Increased VTA metabolism and functional connectivity in MKP-2-/- mice.
14C-2-DG autoradiographic imaging has been used to identify localised changes in brain 
metabolism in numerous studies (Dawson et al., 2012, 2013). Recently, studies have utilised 
mathematical algorithms to investigate alterations in connectivity between brain regions using 
14C-2-DG data (Dawson et al., 2012, 2013, 2015). As MAPK pathways have diverse roles 
within the CNS, we examined whether MKP-2 deletion led to alterations in metabolism in 
discrete brain regions and disrupted functional brain connectivity. Our 14C-2-DG data indicates 
that LCGU is significantly and selectively increased in the VTA of MKP-2-/- mice and that its 
functional connectivity is altered in a region-specific manner. This includes altered functional 
connectivity between the VTA and subfields of the prefrontal cortex, striatum, and the 
hippocampus (Figure 1, Tables 1 & 2), which is consistent with our previous observation of 
altered hippocampal-dependent spatial learning in these mice (Abdul Rahman et al., 2016). The 
mesolimbic system is established as an essential component of the reward system with the VTA 
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and NAc playing critical roles in reward processing (Cohen et al., 2012; Creed and Lüscher, 
2013), with altered reward processing being associated with alterations in MAPK activity (Jia 
et al., 2013; Ciccarelli and Giustetto, 2014). Given our understanding of VTA function and our 
observations regarding increased VTA metabolism and altered functional connectivity in MKP-
2-/- mice, we hypothesised that these alterations would lead to changes in relevant behavioural 
tests, including tests characterising reward processing.
4.2 |  sEPSC frequency onto VTA dopaminergic neurons is increased in MKP-2-/- mice.
Having established that MKP-2 deletion leads to changes in VTA metabolism and functional 
connectivity, we next examined the alterations in VTA neuronal excitability and synaptic 
activity underlying these observations. An increase in sEPSC frequency, but not amplitude, 
onto IH positive VTA neurons in MKP-2-/- mice was observed, indicating that presynaptic 
functional changes result in enhanced glutamate release. This increased excitatory drive may 
contribute to the increased VTA metabolism observed in these mice. However, the exact 
mechanisms that underlie this increased sEPSC frequency remain elusive. One possibility is 
that ERK activity is increased presynaptically in the absence of MKP-2, which would lead to 
changes in presynaptic release machinery and/or the number of docked vesicles (Kushner, 
2005; Giachello et al., 2010). This finding may account for the increased sEPSC frequency 
observed in the present study. However, given that ERK activity has previously been shown to 
be unaltered in MKP-2-/- mice when examined in tissue from various brain regions (Abdul 
Rahman et al., 2016), whether presynaptically localised changes in ERK activity in the VTA 
accounts for this remains unknown. To date ERK activity in synapses onto VTA neurons has 
not yet been characterised in MKP-2-/- mice, so the possibility of a selective increase in this 
region remains a possibility that certainly warrants further investigation. Additionally, it should 
also be noted that whilst the VTA contains a heterogeneous population of neuronal types 
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including dopaminergic, GABAergic and glutamatergic neurons (Nair-Roberts et al., 2008; 
Creed et al., 2014; Morales and Root, 2014; Walsh and Han, 2014), here we have focussed on 
glutamatergic synaptic activity onto VTA DA neurons. Hence, it would be interesting to 
characterise the synaptic activity onto other identified neuronal subtypes within the VTA. 
Strikingly, increased synaptic connectivity in the VTA is observed following injections of 
rewarding drugs of abuse (Ungless et al., 2001; Oliva and Wanat, 2016; Francis et al., 2018), 
with these drug-induced increases in synaptic strength being primarily mediated by 
postsynaptic changes.  In contrast, the classic interpretation of our findings in relation to 
increased sEPSC frequency but not amplitude, are that these changes are mediated 
presynaptically. This suggestion is also consistent with the observation that 14C-2-DG and 
glucose metabolism largely reflects local synaptic activity in the brain region of interest. 
However, it would be interesting to further characterise the functional basis of the increased 
sEPSCs seen in the VTA of MKP2-/- mice using paired pulse facilitation and AMPA/NMDA 
ratio paradigms in order to identify the exact locus of increased sEPSC frequency.  
4.3 |  Altered VTA function  is not due to structural changes in MKP-2-/- mice.
Having established that MKP-2 deletion leads to changes in VTA function, we examined 
whether structural changes within the VTA accounted for these observations. We found that 
the density of dopaminergic neurons, the density of all nuclei, and the ratio of dopaminergic 
neurons to all nuclei were not altered in MKP-2-/- mice, indicating that VTA structural changes 
do not underlie our observations of altered VTA metabolism and functional connectivity in 
these animals. This raises the question as to the nature of the physiological changes within the 
VTA that underlie our observations, and generally rules out the contribution of gross cellular 
neurodevelopmental alterations as the primary mechanism underlying VTA dysfunction in 
MKP-2-/- mice. However, at present it is still unclear as to whether altered VTA metabolism 
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and connectivity in MKP-2-/- mice is mediated by more subtle development effects, for example 
through effects on neuronal differentiation (Kim et al., 2015), or whether the effect of a lifelong 
loss of MKP-2 function can be reversed by acutely rescuing VTA MKP-2 function in these 
animals. While our observation that VTA dopaminergic neuronal density is not altered in MKP-
2-/- mice is suggestive that reduced VTA LCGU is not mediated by developmental proliferation 
defects, at least for DA neurons, this potential mechanism requires further investigation and the 
impact on other neuronal cell types still remains as a plausible contributory mechanism.
4.4 |  Impaired amphetamine-induced locomotor activity but increased sucrose preference 
in MKP-2-/- mice.
Since it is well established that rewarding drugs of abuse modulate synaptic transmission and 
plasticity onto the dopaminergic VTA neurons (Ungless et al., 2001; Oliva and Wanat, 2016; 
Francis et al., 2018) and we observed synaptic dysfunction in the VTA of these animals, we 
investigated the effect of amphetamine injection in MKP-2-/- mice using the open field test. 
Surprisingly, locomotor activity was decreased in MKP-2-/- mice injected with amphetamine 
compared with that observed in MKP-2+/+ mice. There is much debate regarding the brain 
regions and mechanisms involved in psychostimulant-induced behaviour and addiction but 
altered VTA connectivity is strongly implicated  (Hyman and Malenka, 2001; Morales and 
Margolis, 2017). In particular, it is well established that psychostimulant drugs, including 
amphetamine, result in increased extracellular DA levels that contribute to the resultant 
hyperlocomotion (Heshmati and Russo, 2015; Morales and Margolis, 2017). Indeed, recent 
studies have proposed a key role for VGLUT2 containing VTA DA neuronal connectivity with 
the NAc in psychostimulant-induced behaviour and hyperlocomotion (Birgner et al., 2010; 
Hnasko et al., 2010; Fortin et al., 2012; Papathanou et al., 2018).  The similarity between these 
Page 51 of 74
20
findings and our own in regard to impaired response to amphetamine and the reduced VTA-
NAc functional connectivity seen in MKP-2-/- mice is intriguing and warrants further work.
To examine whether the mesolimbic system dysfunction seen in MKP-2-/- mice results in 
alterations in reward processing, we used the sucrose preference test, an established method for 
investigating hedonic state. Consistent with an increase in VTA LCGU metabolism, MKP-2-/- 
mice displayed a greater preference for sucrose than MKP-2+/+ mice. In agreement with our 
findings, previous studies have revealed that optogenetic inhibition of VTA dopaminergic 
neurons leads to decreased sucrose preference in mice (Cohen et al., 2012; Nieh et al., 2015). 
Furthermore, increased VTA activity is associated with increased reward seeking behaviour 
(Kempadoo et al., 2013; Creed et al., 2014) and our observations of altered hippocampal-VTA-
accumbens functional connectivity in MKP-2-/- mice are consistent with the established role of 
this neural circuit in reward processing and novelty detection (Lisman and Grace, 2005; 
Morales and Margolis, 2017). Hence, this may also contribute to the altered sucrose preference 
seen in these animals.  Intriguingly, these data suggest that the decreased expression of MKP-
2 seen in the brains of patients with depression (Dwivedi et al., 2001) and schizophrenia 
(Kyosseva et al., 1999), may contribute to the anhedonia seen in these disorders, which may be 
mediated, in part, by the influence of MKP-2 on the VTA and mesolimbic reward system 
function. Clearly, further studies are required to elucidate the potential role of MKP-2 
dysfunction in the aetiology of these disorders and MKP-2’s potential contribution to altered 
reward processing and motivation.
Our data reveal contrasting results between increased preference for the natural reward of 
sucrose compared to the drug-induced effects of amphetamine. Whilst a clear rationale for this 
is unknown, it is generally accepted that amphetamine-induced hyperlocomotion is a selective 
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challenge of the dopaminergic system and reflects increased DA levels in mesolimbic regions, 
whereas sucrose preference is proposed to engage several neuronal circuits/systems (Heshmati 
and Russo, 2015; Morales and Margolis, 2017). These contrasting results could be examined 
further through targeted deletion of VTA MKP-2 in wild-type mice that would allow normal 
development and the determination of the acute effects of MKP-2 signalling, or via targeted 
MKP-2 reintroduction into the VTA of MKP-2-/- mice in order to rescue the phenotypes 
observed here. However, these experiments are clearly beyond the scope if this initial unbiased 
whole brain approach.
Taken together, the present study reveals a novel role for MKP-2 in reward processing 
paralleled by concomitant changes in VTA function and functional connectivity.  These 
findings indicate that MKP-2 may play role in the altered reward processing that occurs in CNS 
disorders associated with MKP-2 dysfunction, particularly those in which altered reward 
processing is prominent. 
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Figure Captions
Figure 1. Altered VTA metabolism and functional connectivity in MKP-2-/- mice. (a) LCGU is 
selectively increased in the VTA of MKP-2-/- mice (n = 11) compared to MKP-2+/+ control mice 
(n = 10) but not in (b) the ventral hippocampal CA1 region or (c) the central amygdala. (d-i) 
Summary statistical diagrams showing altered VTA functional connectivity in MKP-2-/- mice. 
Brain section figures are modified from the Allen mouse brain atlas (http://mouse.brain-
map.org/static/atlas). Blue denotes regions that have significantly lost functional connectivity 
with the VTA in MKP-2-/- mice. Red denotes regions that show significantly gained functional 
connectivity to the VTA in MKP-2-/- but not MKP-2+/+ mice. Yellow highlights the anatomical 
localisation of the VTA. (j) The functional connectivity heatmap also shows the lost (blue) and 
gained (red) alterations in VTA functional connectivity in MKP2-/- mice. Amyg. = Amygdala, 
Dorsal Hip.= Dorsal Hippocampus, Ventral Hip.= Ventral Hippocampus, Aud. = Auditory 
System, Multi.= Mutlimodal regions. Regional abbreviations and their systems are shown in 
Table 1. Differences in LCGU between groups was analysed using unpaired two-tailed 
Student’s t-test with * p < 0.05 vs MKP-2+/+ controls. Full LCGU and functional connectivity 
data are shown in Tables 1 and 2 respectively.
Figure 2. Increased sEPSC frequency onto VTA DA neurons in MKP-2-/- mice. (a)  
Representative images and traces of co-localisation of biocytin (magenta) filled IH positive 
neuron and tyrosine hydroxylase (TH; green) in the VTA. (b-c) Representative IH traces 
recorded from MKP-2+/+ and MKP-2-/- VTA neurons respectively. (d) IH amplitude is unaffected 
in VTA DA neurons from MKP-2-/- mice when compared to MKP-2+/+ controls (n = 6). (e-f)  
Representative sEPSC traces from MKP+/+ and MKP-/- mice respectively. (g) sEPSC frequency 
is increased in MKP-2-/- slices (n = 6) compared to MKP+/+ slices (n = 6) whereas (h) sEPSC 
amplitude is unchanged. Data were analysed using 2-way repeated-measures ANOVA followed 
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by Bonferroni post-hoc correction (IH) and two-tailed Mann-Whitney U non-parametric tests 
(sEPSCs) with * p < 0.05 vs MKP-2+/+ controls. N is equal to one neuron per slice per animal 
with all IH positive neurons confirmed to be DA neurons (TH positive) post experiment.
Figure 3. No change in dopamine neuron number in MKP-2-/- mice. (a) Immunostaining for 
tyrosine hydroxylase (TH; green) and DAPI (blue) appeared normal in MKP-2-/- mice (n = 6) 
compared to MKP-2+/+ control mice (n=6). (b) Quantitative analyses revealed no significant 
differences between the densities of dopaminergic (TH+ve) neurons, total cell bodies (DAPI) 
and the ratio of TH / total cells in MKP-2-/- mice compared to MKP-2+/+ control mice. Data 
analysed using unpaired two-tailed Student’s t-tests.
Figure 4. Reduced amphetamine-induced hyperlocomotion but increased sucrose preference 
in MKP-2-/- mice. (a) Amphetamine (3mg kg-1, i.p.)-induced hyperlocomotion is significantly 
attenuated in MKP-2-/- mice (n=8 for both genotypes). (b) Sucrose intake (1% solution) in 
relation to total fluid intake is significantly increased in MKP-2-/- mice compared to MKP-2+/+ 
mice on trial days 2 and 3 (n=16 for both genotypes). Both sets of data were analysed using 2-
way repeated-measures ANOVA followed by Bonferroni post-hoc correction with * p < 0.05 
vs MKP-2+/+ controls.
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Table 1. LCGU is increased in the VTA of MKP-2-/- mice.  
 MKP-2+/+ MKP-2-/-  
 mean  S.E. mean  S.E. % difference
Prefrontal Cortex
Lateral Orbital Cortex (LO) 1.64 ± 0.04 1.64 ± 0.03 0
anterior Prelimbic Cortex (aPrL) 1.15 ± 0.03 1.18 ± 0.02 2
Dorsolateral Orbital Cortex (DLO) 0.89 ± 0.02 0.85 ± 0.02 -5
Frontal Association Area (FRA) 1.20 ± 0.02 1.16 ± 0.02 -3
medial Prelimbic Cortex (mPrL) 1.14 ± 0.03 1.14 ± 0.03 0
Infralimbic Cortex (IL) 0.93 ± 0.03 0.90 ± 0.02 -3
Cingulate Cortex (Cg1) 1.22 ± 0.03 1.26 ± 0.02 4
Cortex
Primary Motor Cortex (M1) 1.24 ± 0.02 1.19 ± 0.03 -4
Sensory Cortex Barrel Field (SC-BF) 1.31 ± 0.03 1.34 ± 0.05 2
Primary Somatosensory Cortex (S1) 1.33 ± 0.03 1.23 ± 0.04 -7
Piriform Cortex (Piri) 1.55 ± 0.03 1.49 ± 0.03 -4
Insular Cortex (Ins) 0.81 ± 0.01 0.80 ± 0.02 -2
Entorhinal Cortex (EntC) 0.92 ± 0.02 0.91 ± 0.02 -1
Primary Visual Cortex (V1) 1.20 ± 0.05 1.28 ± 0.05 7
Mesolimbic System
Ventral Tegmental Area (VTA) 1.24 ± 0.03 1.33 ± 0.03 7*
Nucleus Accumbens Core (NacC) 0.93 ± 0.02 0.89 ± 0.02 -4
Nucleus Accumbens Shell (NacS) 1.04 ± 0.03 1.02 ± 0.01 -1
Basal Ganglia
Dorsolateral Striatum (DLST) 1.30 ± 0.02 1.30 ± 0.02 0
Ventromedial Striatum (VMST) 1.29 ± 0.02 1.26 ± 0.03 -3
Globus Pallidus (GP) 0.92 ± 0.03 0.93 ± 0.02 2
Substantia Nigra pars Reticulata (SNR) 0.81 ± 0.02 0.81 ± 0.02 0
Substantia Nigra pars Compacta (SNC) 1.06 ± 0.03 1.05 ± 0.02 -1
Thalamus
Anteromedial Thalamus (AMthal) 1.64 ± 0.05 1.68 ± 0.03 3
Anteroventral Thalamus (AVthal) 1.80 ± 0.05 1.85 ± 0.05 3
Mediodorsal Thalamus (MDthal) 1.42 ± 0.02 1.46 ± 0.04 3
Venterolateral Thalamus (VLthal) 1.50 ± 0.04 1.49 ± 0.03 0
Centrolateral Thalamus (CLthal) 1.15 ± 0.04 1.22 ± 0.04 6
Ventromedial Thalamus (VMthal) 1.36 ± 0.04 1.36 ± 0.04 0
dorsal Reticular Thalamus (dRT) 1.10 ± 0.03 1.17 ± 0.04 7
Nucleus Reuniens (Re) 1.16 ± 0.04 1.19 ± 0.05 3
Amygdala
Basolateral Amygdala (BLA) 0.87 ± 0.03 0.86 ± 0.02 -1
Central Amygdala (CeA) 0.87 ± 0.02 0.84 ± 0.02 -3
Medial Amygdala (MeA) 0.73 ± 0.02 0.75 ± 0.02 2




Dorsal Hippocampus -Molecular Layer (DH-
ML) 1.27 ± 0.04 1.27 ± 0.04 0
Dorsal Hippocampus-CA1 (DH-CA1) 0.84 ± 0.02 0.86 ± 0.03 2
Dorsal Hippocampus-CA2 (DH-CA2) 0.78 ± 0.02 0.77 ± 0.02 -1
Dorsal Hippocampus-CA3 (DH-CA3) 0.81 ± 0.02 0.79 ± 0.02 -3
Dorsal Hippocampus-DG (DH-DG) 0.78 ± 0.03 0.78 ± 0.03 0
Ventral
Ventral Hippocampus-Dorsal Subiculum (VH-
DS) 1.17 ± 0.04 1.19 ± 0.02 2
Ventral Hippocampus-CA1 (VH-CA1) 0.96 ± 0.04 0.95 ± 0.02 -1
Ventral Hippocampus-CA2 (VH-CA2) 0.87 ± 0.02 0.85 ± 0.02 -3
Ventral Hippocampus-CA3 (VH-CA3) 0.68 ± 0.02 0.68 ± 0.02 -1
Ventral Hippocampus-DG (VH-DG) 0.70 ± 0.03 0.68 ± 0.02 -2
Ventral Hippocampus-ML (VH-ML) 1.11 ± 0.03 1.08 ± 0.02 -2
Septum/Diagonal Band of Broca
Medial Septum (MS) 0.94 ± 0.03 0.91 ± 0.02 -2
Vertical Limb of the Diagonal Band of Broca 
(VDB) 1.02 ± 0.02 1.00 ± 0.02 -1
Horizontal Limb of the Diagonal Band of Broca 
(HDB) 1.07 ± 0.02 1.06 ± 0.02 -1
Auditory System
Medial Geniculate (MG) 1.21 ± 0.04 1.26 ± 0.04 4
Inferior Colliculus (IC) 2.17 ± 0.10 2.12 ± 0.09 -3
Neuromodulatory
Dorsal Raphé (DR) 0.87 ± 0.03 0.90 ± 0.02 4
Median Raphé (MR) 1.18 ± 0.03 1.19 ± 0.03 1
Multimodal
Mamillary Body (MB) 1.74 ± 0.04 1.74 ± 0.05 0
Lateral Habenula (LHab) 1.34 ± 0.03 1.41 ± 0.04 5
Data shown as the mean ± S.E.M. 14C-2-deoxyglucose uptake ratio. Data analysed using Student’s t-
test with * p < 0.05 vs MKP-2+/+ controls, n ≥ 10 mice per genotype.
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Table 2. Altered VTA Connectivity in MKP-2-/- mice
 MKP-2+/+ MKP-2-/-







Lateral Orbital Cortex (LO) 0.92 ± 0.03 0.56 ± 0.09 ns
anterior Prelimbic Cortex (aPrL) 0.66 ± 0.10 1.07* ± 0.04 0.042 2.166
Dorsolateral Orbital Cortex (DLO) 0.45 ± 0.05 0.74* ± 0.05 0.026 2.395
Frontal Association Area (FRA) 0.85 ± 0.02 1.11 ± 0.10 ns
medial Prelimbic Cortex (mPrL) 0.96 ± 0.03 1.20 ± 0.10 ns
Infralimbic Cortex (IL) 1.35 ± 0.03 0.69** ± 0.07 0.005 -3.118
Cingulate Cortex (Cg1) 0.97 ± 0.03 0.75 ± 0.06 ns
Cortex
Primary Motor Cortex (M1) 0.72 ± 0.06 1.30* ± 0.10 0.010 2.831
Sensory Cortex Barrel Field (SC-BF) 0.36 ± 0.06 0.73 ± 0.04 ns
Primary Somatosensory Cortex (S1) 1.14 ± 0.03 1.30 ± 0.09 ns
Piriform Cortex (Piri) 0.71 ± 0.08 0.52 ± 0.10 ns
Insular Cortex (Ins) 1.41 ± 0.05 0.67** ± 0.04 0.005 -3.118
Entorhinal Cortex (EntC) 1.10 ± 0.03 1.56** ± 0.07 0.005 3.118
Primary Visual Corex (V1) 0.91 ± 0.03 0.68** ± 0.04 0.005 -3.118
Mesolimbic System
Nucleus Accumbens Core (NacC) 0.86 ± 0.06 0.69 ± 0.05 ns
Nucleus Accumbens Shell (NacS) 0.96 ± 0.09 0.40** ± 0.07 0.005 -3.118
Basal Ganglia
Dorsolateral Striatum (DLST) 0.87 ± 0.05 1.10 ± 0.06 ns
Ventromedial Striatum (VMST) 0.39 ± 0.05 1.53** ± 0.10 0.005 3.118
Globus Pallidus (GP) 0.51 ± 0.05 1.20** ± 0.10 0.005 3.118
Substantia Nigra pars Reticulata (SNR) 1.22 ± 0.04 0.54** ± 0.11 0.005 -3.118
Substantia Nigra pars Compacta (SNC) 1.38 ± 0.02 2.59** ± 0.07 0.005 3.118
Thalamus
Anteromedial Thalamus (AMthal) 0.61 ± 0.07 0.55 ± 0.07 ns
Anteroventral Thalamus (AVthal) 0.60 ± 0.10 1.16** ± 0.07 0.005 3.118
Mediodorsal Thalamus (MDthal) 0.69 ± 0.04 0.83 ± 0.05 ns
Venterolateral Thalamus (VLthal) 1.25 ± 0.05 1.01 ± 0.06 ns
Centrolateral Thalamus (CLthal) 1.44 ± 0.02 0.82** ± 0.06 0.005 -3.118
Ventromedial Thalamus (VMthal) 1.47 ± 0.01 1.01** ± 0.07 0.005 3.118
dorsal Reticular Thalamus (dRT) 0.40 ± 0.08 0.49 ± 0.05 ns
Nucleus Reuniens (Re) 0.91 ± 0.02 1.04 ± 0.07 ns
Amygdala
Basolateral Amygdala (BLA) 1.48 ± 0.03 0.79** ± 0.05 0.005 -3.118
Central Amygdala (CeA) 0.58 ± 0.06 0.48 ± 0.04 ns
Medial Amygdala (MeA) 1.23 ± 0.04 0.95* ± 0.06 0.005 3.118




Dorsal Hippocampus -Molecular Layer (DH-ML) 0.85 ± 0.04 1.14* ± 0.05 0.010 2.831
Dorsal Hippocampus-CA1 (DH-CA1) 1.14 ± 0.02 0.68** ± 0.06 0.005 -3.118
Dorsal Hippocampus-CA2 (DH-CA2) 1.26 ± 0.03 1.26 ± 0.04 ns
Dorsal Hippocampus-CA3 (DH-CA3) 1.20 ± 0.05 0.96 ± 0.06 ns
Dorsal Hippocampus-DG (DH-DG) 0.82 ± 0.03 1.40** ± 0.04 0.005 3.118
Ventral
Ventral Hippocampus-Dorsal Subiculum (VH-DS) 1.19 ± 0.01 0.45** ± 0.05 0.005 -3.118
Ventral Hippocampus-CA1 (VH-CA1) 0.88 ± 0.03 0.70 ± 0.07 ns
Ventral Hippocampus-CA2 (VH-CA2) 0.90 ± 0.03 1.00 ± 0.06 ns
Ventral Hippocampus-CA3 (VH-CA3) 0.85 ± 0.04 0.81 ± 0.08 ns
Ventral Hippocampus-DG (VH-DG) 0.73 ± 0.04 0.90 ± 0.06 ns
Ventral Hippocampus-ML (VH-ML) 1.09 ± 0.04 1.06 ± 0.16 ns
Septum/Diagonal Band of Broca
Medial Septum (MS) 1.34 ± 0.04 1.17 ± 0.05 ns
Vertical Limb of the Diagonal Band of Broca (VDB) 0.31 ± 0.06 0.45 ± 0.08 ns
Horizontal Limb of the Diagonal Band of Broca (HDB) 0.60 ± 0.04 0.56 ± 0.04 ns
Auditory System
Medial Geniculate (MG) 0.81 ± 0.07 0.64 ± 0.04 ns
Inferior Colliculus (IC) 0.97 ± 0.03 0.62** ± 0.05 0.005 -3.118
Neuromodulatory
Dorsal Raphé (DR) 0.80 ± 0.06 0.63 ± 0.04 ns
Median Raphé (MR) 0.99 ± 0.07 0.64* ± 0.06 0.042 -2.166
Multimodal
Mamillary Body (MB) 1.66 ± 0.08 0.74** ± 0.05 0.005 -3.118
Lateral Habenula (LHab) 0.78 ± 0.07 0.81 ± 0.04 ns
Data shown as the mean ± S.E.M of the VIP statistic gained from PLSR analysis. Bold denotes 
those RoI considered to be functionally connected to the VTA within each experimental group 
(where the 95% confidence interval of the VIP statistic for a given region exceeds the 0.8 threshold). 
Data analysed using Student’s t-test with Bonferroni correction. * denotes p < 0.05 and ** denotes 
p < 0.01 significant difference in the VIP statistic in MKP-2-/- mice relative the MKP-2+/+ controls. 
Only RoI showing significantly altered functional connectivity to the VTA in MKP-2-/- mice are 
shown. n ≥ 10 mice per genotype. 
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Supplementary Table 1 – Representative Shapiro-Wilk normality tests for data presented in 
figures 1-4.
Figure 1: Local cerebral glucose utilisation and functional brain connectivity analysis.
Region W-statistic P value Pass / fail Statistical test 
used
VTA +/+ 0.904 0.207 Pass
VTA -/- 0.867 0.093 Pass
two-tailed 
unpaired t-test
Hippo +/+ 0.630 0.630 Pass
Hippo -/- 0.356 0.356 Pass
two-tailed 
unpaired t-test
CeA +/+ 0.272 0.272 Pass
CeA -/- 0.833 0.833 Pass
two-tailed 
unpaired t-test


















Figure 3: Immunohistochemistry data
TH density +/+ 0.923 0.529 Pass











TH/DAPI +/+ 0.578 0.578 Pass
TH/DAPI -/- 0.146 0.146 Pass
two-tailed 
unpaired t-test
Figure 4: Sucrose preference test
SPT day 1 +/+ 0.926 0.210 Pass
SPT day 1 -/- 0.914 0.135 Pass
two-tailed 
unpaired t-test
SPT day 2 +/+ 0.952 0.529 Pass
SPT day 2 -/- 0.951 0.501 Pass
two-tailed 
unpaired t-test
SPT day 3 +/+ 0.953 0.541 Pass
SPT day 2 -/- 0.951 0.511 Pass
two-tailed 
unpaired t-test
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We examined whether the mitogen-activated protein kinase phosphatase (MKP-2) plays a global 
role in modulating brain function.  Using MKP-2-/- mice, we reveal that ventral tegmental area 
(VTA) function and connectivity is altered, which is associated with increased excitatory drive 
onto VTA DA neurons but no change in VTA structure.  In addition, behavioural tests indicate 
that MKP-2 plays a role in reward processing. Hence, we suggest that MKP-2 plays a role in 
modulating VTA function.
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